StockDuty ← Dashboard Aug 25, 2026 04:11 PM ET
CatalystFDA/Bio

Anavex Life Sciences Advances Alzheimer’s Phase 3 Planning as Cash Runway Extends Into Fiscal 2028

Phase 3 planning and cash runway into 2028 signal reduced financing risk.

Phase 3 planning and cash runway into 2028 signal reduced financing risk.
Sources